Constructing and implementing a performance evaluation indicator set for artificial intelligence decision support systems in pediatric outpatient clinics: an observational study
- PMID: 38914707
- PMCID: PMC11196575
- DOI: 10.1038/s41598-024-64893-w
Constructing and implementing a performance evaluation indicator set for artificial intelligence decision support systems in pediatric outpatient clinics: an observational study
Abstract
Artificial intelligence (AI) decision support systems in pediatric healthcare have a complex application background. As an AI decision support system (AI-DSS) can be costly, once applied, it is crucial to focus on its performance, interpret its success, and then monitor and update it to ensure ongoing success consistently. Therefore, a set of evaluation indicators was explicitly developed for AI-DSS in pediatric healthcare, enabling continuous and systematic performance monitoring. The study unfolded in two stages. The first stage encompassed establishing the evaluation indicator set through a literature review, a focus group interview, and expert consultation using the Delphi method. In the second stage, weight analysis was conducted. Subjective weights were calculated based on expert opinions through analytic hierarchy process, while objective weights were determined using the entropy weight method. Subsequently, subject and object weights were synthesized to form the combined weight. In the two rounds of expert consultation, the authority coefficients were 0.834 and 0.846, Kendall's coordination coefficient was 0.135 in Round 1 and 0.312 in Round 2. The final evaluation indicator set has three first-class indicators, fifteen second-class indicators, and forty-seven third-class indicators. Indicator I-1(Organizational performance) carries the highest weight, followed by Indicator I-2(Societal performance) and Indicator I-3(User experience performance) in the objective and combined weights. Conversely, 'Societal performance' holds the most weight among the subjective weights, followed by 'Organizational performance' and 'User experience performance'. In this study, a comprehensive and specialized set of evaluation indicators for the AI-DSS in the pediatric outpatient clinic was established, and then implemented. Continuous evaluation still requires long-term data collection to optimize the weight proportions of the established indicators.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
References
-
- Administration., U. F. a. D. FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems: FDA news release. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm604357.htm. Published April 11, 2018. Accessed 17 April 2024.
Publication types
MeSH terms
Grants and funding
- 21511104502/Science and Technology Commission of Shanghai Municipality
- 2021ZD0113504/National Key R&D Program of China
- 21002411800/2021 Artificial Intelligence Technology Support Special Directional Project (The second batch)
- SHDC22021305-A, SHDC22021305-B/Shanghai Municipal Hospital Pediatric Specialist Alliance
LinkOut - more resources
Full Text Sources